Cargando…

Challenges in COVID-19 drug treatment in patients with advanced liver diseases: A hepatology perspective

The global incidence of coronavirus disease 2019 (COVID-19) continues to increase despite health care efforts. The disease is caused by coronavirus 2 with high transmission and mortality rates. Little is known about the management of COVID-19 in advanced liver disease. The aim of work was to propose...

Descripción completa

Detalles Bibliográficos
Autores principales: Hanafy, Amr Shaaban, Abd-Elsalam, Sherief
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739155/
https://www.ncbi.nlm.nih.gov/pubmed/33362383
http://dx.doi.org/10.3748/wjg.v26.i46.7272